Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
10 Drugs Approved for Primary Care: Q1 2025
Review 10 new FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for UTIs, acute pain, and more.
The first quarter of 2025 brought a wave of new FDA drug approvals, several of which have direct relevance for primary care. In this slideshow, we highlight 10 new therapies that may soon find a place in your prescribing routine. Click through the slides above for details on the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, a first-in-class nonopioid analgesic indicated for moderate-to-severe acute pain, a vaccine that provides coverage against 5 major serogroups of Neisseria meningitidis that affect young people, and 7 more.
